| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 2, 2812-2818, Copyright © 1988 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
DA Weigent, JB Baxter, WE Wear, LR Smith, KL Bost and JE Blalock
Department of Physiology and Biophysics, University of Alabama, Birmingham 35294.
In the present study, we evaluated whether mononuclear leukocytes could synthesize and secrete growth hormone (GH) in vitro. By using RNA slot blot analysis, we detected maximum spontaneous levels of specific GH mRNA in the cytoplasm of rat leukocytes after a 4-h incubation. Northern gel analysis demonstrated that the specific leukocyte GH RNA was polyadenylated and had a molecular mass of 1.0 kb. Further studies using immunofluorescence, antibody affinity chromatography, and Sephacryl gel filtration indicate that leukocytes secrete a high molecular weight (greater than 300,000) and a low molecular weight (approximately 22,000) immunoreactive GH (irGH). A substantial amount of the high molecular weight irGH can be converted to the lower molecular weight form after reduction with mercaptoethanol. The irGH appeared to be de novo synthesized because it could be radiolabeled with tritiated amino acids and its production could be blocked by previous incubation of leukocytes with cycloheximide. The replication of Nb2 rat node lymphoma cells was stimulated by affinity-purified human lymphocyte-derived irGH. The growth stimulation was blocked by specific antibodies to hGH. We conclude that lymphocytes produce an irGH that is similar to if not identical to pituitary GH in terms of bioactivity, antigenicity, and molecular weight. The findings demonstrate a potential regulatory loop between the immune and neuroendocrine tissues.
This article has been cited by other articles:
|
|
 |
|
  M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Leung, C. Howe, L. Y.-Y. Gui, G. Trout, J. D. Veldhuis, and K. K. Y. Ho Physiological and pharmacological regulation of 20-kDa growth hormone Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E836 - E843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Welniak, R. Sun, and W. J. Murphy The role of growth hormone in T-cell development and reconstitution J. Leukoc. Biol., March 1, 2002; 71(3): 381 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-H. Zhou and J. K. Bubien Nongenomic regulation of ENaC by aldosterone Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1118 - C1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Recher, M. Raccurt, A. Lambert, P. E. Lobie, H. C. Mertani, and G. Morel Prenatal and Adult Growth Hormone Gene Expression in Rat Lymphoid Organs J. Histochem. Cytochem., March 1, 2001; 49(3): 347 - 354. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. H. Zarkesh-Esfahani, O. Kolstad, R. A. Metcalfe, P. F. Watson, S. Von Laue, S. Walters, A. Revhaug, A. P. Weetman, and R. J. M. Ross High-Dose Growth Hormone Does Not Affect Proinflammatory Cytokine (Tumor Necrosis Factor-{alpha}, Interleukin-6, and Interferon-{gamma}) Release from Activated Peripheral Blood Mononuclear Cells or after Minimal to Moderate Surgical Stress J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3383 - 3390. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Beuschlein, C. J. Strasburger, V. Siegerstetter, D. Moradpour, P. Lichter, M. Bidlingmaier, H. E. Blum, and M. Reincke Acromegaly Caused by Secretion of Growth Hormone by a Non-Hodgkin's Lymphoma N. Engl. J. Med., June 22, 2000; 342(25): 1871 - 1876. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Fang, R. Steinmetz, D. W. King, P. Zeng, C. Vogelweid, S. Cooper, G. Hangcoc, H. E. Broxmeyer, and O. H. Pescovitz Development of a Transgenic Mouse That Overexpresses a Novel Product of the Growth Hormone-Releasing Hormone Gene Endocrinology, April 1, 2000; 141(4): 1377 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Vines and D. A. Weigent Identification of SP3 as a Negative Regulatory Transcription Factor in the Monocyte Expression of Growth Hormone Endocrinology, March 1, 2000; 141(3): 938 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kooijman, A. Malur, S. C. van Buul-Offers, and E. L. Hooghe-Peters Growth Hormone Expression in Murine Bone Marrow Cells Is Independent of the Pituitary Transcription Factor Pit-1 Endocrinology, September 1, 1997; 138(9): 3949 - 3955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Postel-Vinay, V. de Mello Coelho, M.-C. Gagnerault, and M. Dardenne Growth Hormone Stimulates the Proliferation of Activated Mouse T Lymphocytes Endocrinology, May 1, 1997; 138(5): 1816 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
